Cardiovascular Systems (CSII) Stock Price, News & Analysis

Cardiovascular Systems, Inc. (NASDAQ:CSII) posted its quarterly earnings results on Wednesday, February, 8th. The medical device company reported ($0.20) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.15) by $0.05. The medical device company earned $61.45 million during the quarter, compared to analyst estimates of $63.06 million. Cardiovascular Systems had a negative trailing twelve-month return on equity of 15.39% and a negative net margin of 15.79%. The business's revenue for the quarter was up 3.9% on a year-over-year basis. During the same period last year, the company earned ($0.23) EPS.

35 employees have rated Cardiovascular Systems Chief Executive Officer Scott Ward on Glassdoor.com. Scott Ward has an approval rating of 81% among the company's employees. 83.0% of employees surveyed would recommend working at Cardiovascular Systems to a friend.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardiovascular Systems investors own include Gilead Sciences (GILD), AbbVie (ABBV), Advanced Micro Devices (AMD), Medtronic (MDT), Pfizer (PFE), ACADIA Pharmaceuticals (ACAD), Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK) and Procter & Gamble (PG).